Living Forever The article explores Peter Diamandis’s concept of Longevity Escape Velocity (LEV), where scientific advances extend life expectancy by more than a year annually, making aging a solvable problem. It details four key scientific approaches: epigenetic cellular reprogramming, senolytics, gene editing, and organ replacement, noting both potential benefits and significant risks like cancer. While immortality remains speculative, the pursuit of longevity is expected to yield substantial benefits for those with serious health conditions.

• Longevity Escape Velocity (LEV) is the concept that annual medical advances extend life expectancy by more than a year, making aging an engineering problem.
• Epigenetic cellular reprogramming aims to restore youthful cell function, but carries risks of cell identity loss and cancer.
• Senolytics target and remove senescent (‘zombie’) cells that contribute to aging and inflammation.
• Gene editing, such as CRISPR, can modify DNA to reduce disease risk and enhance repair, but aging is complex and not tied to a single gene.
• Organ replacement through transplantation is established but faces scarcity issues; lab-grown organs are still theoretical.
• While immortality is speculative, the massive investment in longevity research will likely benefit individuals with chronic diseases and medical needs. Continue reading https://foxvector.com/articles/8e4799e7-6462-4730-8913-1e5b85a8a283